Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-04-07

Clinical Trial Update: EngageRx With Integrated Self-Measurement of Blood Pressure [NA]

View source ↗

Summary

A UCSF-sponsored clinical trial evaluating EngageRx with integrated self-measurement of blood pressure for hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EngageRx

Snippet

Sponsor: University of California, San Francisco | Conditions: Hypertension | NA | Status: WITHDRAWN